NEURONAL CELL-SPECIFIC PROMOTER

Details for Australian Patent Application No. 2002304974 (hide)

Owner GARVAN INSTITUTE OF MEDICAL RESEARCH

Inventors SCHOFIELD, Peter, Robert; MORGAN, Branwen, Sarah; MORRIS, Renee

Pub. Number AU-A-2002304974

PCT Number PCT/AU02/00711

PCT Pub. Number WO2002/097092

Priority PR 5512 01.06.01 AU

Filing date 3 June 2002

Wipo publication date 9 December 2002

International Classifications

C12N 015/11 Mutation or genetic engineering - DNA or RNA fragments

C12P 021/02 Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C07K 014/48 Peptides having more than 20 amino acids

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): PR 5512 01.06.01 AU

8 May 2003 Application Open to Public Inspection

  Published as AU-A-2002304974

11 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002304975-EVALUATION SYSTEM AND METHOD

2002304973-Sphingosine kinase interacts with TRAF2 and modulates tumor necrosis factor-induced cellular activity